英国胸科协会肺结节病临床诊治共识解读  

Interpretation of clinical diagnosis and treatment consensus of pulmonary sarcoidosis by British Thoracic Society(BTS)

作　　者：周子靖 彭红[1] Zhou Zijing;Peng Hong(Department of Respiratory and Critical Care Medicine,Xiangya Second Hospital,Central South University,Changsha 410011,China)

机构地区：[1]中南大学湘雅二医院呼吸与危重症医学科,长沙410011

出　　处：《中国医师杂志》2021年第8期1121-1127,共7页Journal of Chinese Physician

基　　金：国家临床重点专科建设项目。

摘　　要：结节病是一种病因及发病机制尚未明确的系统性肉芽肿性疾病,可累及全身多器官组织,其临床表现、治疗反应及预后往往呈现较大的异质性,通常需要个体化的治疗方案和定期的监督随访。为了满足上述临床需求,各国陆续制定结节病的临床诊治规范,这其中就包括2020年12月英国胸科协会(BTS)推出的肺结节病临床共识(简称BTS共识)。本文将BTS共识主要部分进行简要阐述,为广大临床工作者提供参考。Sarcoidosis is a granulomatous disease of unknown etiology that affects almost any organ.The clinical presentation,treatment responsiveness and outcome varies widely between patients.Patients with pulmonary sarcoidosis always need individualized treatment and should be monitored.In order to meet the above clinical needs,countries have successively formulated clinical diagnosis and treatment norms of sarcoidosis.This includes the clinical consensus on pulmonary sarcoidosis(BTS consensus)launched by the British Thoracic Society(BTS)in December 2020.This paper briefly describes the main parts of the BTS consensus to provide reference for the majority of clinical workers.

关 键 词：结节病 肺 临床共识 英国胸科协会 

分 类 号：R563[医药卫生—呼吸系统]